Synopsis of recent research by authors named "Deepika Bhatla"
- Deepika Bhatla's recent research primarily focuses on hemophagocytic lymphohistiocytosis (HLH), particularly evaluating the effectiveness and treatment outcomes of emapalumab, a monoclonal antibody, in patients with rheumatologic disease-associated HLH and primary HLH through the REAL-HLH study conducted across multiple US hospitals.
- The author has also investigated the clinical implications of processing methodologies for umbilical cord blood (UCB) transplantation, including how different processing techniques impact outcomes and the importance of UCB as a stem cell source for various hematologic conditions.
- Bhatla's studies encompass broader areas of hematology, including healthcare disparities in transplantation outcomes related to race/ethnicity, and exploring the molecular underpinnings of autoinflammatory syndromes, highlighting both genetic factors and the therapeutic responses to specific cytokine inhibitors.
